Close

Valeant Pharma (VRX) Receives U.S. Antitrust Clearance for Synergetics Deal

October 5, 2015 5:01 PM EDT Send to a Friend
Valeant Pharma (NYSE: VRX) announced that the applicable waiting period under the Hart-Scott-Rodino Antitrust Improvements Act of 1976 ("HSR") with ...

This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE

Member Login